AU:VFY Stock Latest News
Company AnnouncementsVitrafy Life Sciences Flags Limits on Q1 FY2027 Investor Presentation5d agoVFY
Company AnnouncementsVitrafy accelerates U.S. blood partnerships and enters cell and gene therapy market5d agoVFY
Company AnnouncementsVitrafy Life Sciences Sets Investor Briefing for Q1 FY2027 Results1w agoVFY
Company AnnouncementsVitrafy Life Sciences Adds Employee Incentive Shares to ASX Quotation1w agoVFY
Company AnnouncementsVitrafy Launches Investor Roadshow to Showcase Cryopreservation Platform3w agoVFY
Company AnnouncementsVitrafy partners with Versiti to advance U.S. platelet cryopreservation push1M agoVFYCompany AnnouncementsVitrafy Targets U.S. Cell and Gene Therapy Market with Charter Medical Deal2M agoVFY
Company AnnouncementsVitrafy Life Sciences details ASX-aligned governance framework for FY263M agoVFY
Company AnnouncementsVitrafy Life Sciences Sets Cautious Tone in FY2026 Results Presentation3M agoVFY
Company AnnouncementsVitrafy Life Sciences Narrows Losses and Strengthens Net Assets in 20263M agoVFY
Company AnnouncementsVitrafy Life Sciences to Present FY26 Results in Investor Briefing3M agoVFY
Company AnnouncementsVitrafy advances cryopreservation push with U.S. platelet breakthrough and cash boost3M agoVFYCompany AnnouncementsVitrafy Partners with Hoxworth to Tackle U.S. Red Blood Cell Preservation Crisis3M agoVFY
- Company AnnouncementsVitrafy Director Adjusts Shareholdings as Options Lapse3M agoVFY
- Company AnnouncementsVitrafy Life Sciences Updates Director Brenton Owens’ Equity Interests3M agoVFY
- Company AnnouncementsVitrafy Life Sciences Seeks ASX Quotation for New Share Issue3M agoVFY
- Company AnnouncementsVitrafy to Release Escrowed Shares Following 2026 Financial Results3M agoVFY
Company AnnouncementsVitrafy Scales Back Oversubscribed Share Offer to Fund Growth Push3M agoVFY



